Aleksandra Rizo
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Aleksandra Rizo
The proxy statement of Geron Corp reports total compensation of $1,265,100 for Aleksandra Rizo in fiscal 2021, including a base salary of $506,374. Disclosed compensation is on record for 3 fiscal years. Aleksandra Rizo has spoken on 2 earnings calls across 1 company, most recently for Geron Corp on January 10, 2022.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Geron Corp (GERN)
Source not stated
Start not stated–2022-07-08
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Geron Corp (GERN) | M.D., Ph.D. Executive Vice President, Chief Medical Officer | $506,374 | $1,265,100 |
| 2020 | Geron Corp (GERN) | M.D., Ph.D. Executive Vice President, Chief Medical Officer | $491,625 | $1,134,946 |
| 2019 | Geron Corp (GERN) | M.D., Ph.D. Executive Vice President, Chief Medical Officer | $475,000 | $1,531,454 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.